Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kidney Transplant Preemptive Therapy or Prophylaxis (KPoP) for CMV Prevention in D+R- Recipients

NCT06798909 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06798909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06798909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kidney Transplant Preemptive Therapy or Prophylaxis (KPoP) for CMV Prevention in D+R- Recipients
Lead sponsor
University of California, San Francisco
Phase
Phase 3
Overall status
Recruiting
Start date
July 22, 2025
Completion date
May 31, 2031
Enrollment
360 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus (cmv), kidney diseases, kidney transplant; complications